SecBot SecBot
S-3 ·Filed Feb 24, 2026

MYGN

MYRIAD GENETICS INC
NEUTRAL
Impact 3/10
Horizonweeks Processed8mo ago SEC0000899923-26-000020
Shelf registration, potential dilution
Actionable Insight • Neutral

Monitor for a prospectus supplement, which would signal an actual offering. The timing and type of security issued (equity vs. debt) will determine the impact. Given the company's recent debt issuance and history of losses, an equity offering could be dilutive, while a debt offering could increase leverage.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$4.78
T+0 close · Feb 24, 2026 · via day close
Latest settled
−20.29%
T+60 · $3.81
Vs SPY
−27.24%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Feb 25 $4.78entry
  2. T+1 · 9mo ago +1.67%α +2.22% · $4.86
  3. T+5 · 9mo ago +10.46%α +11.56% · $5.28
  4. T+20 · 8mo ago −2.09%α +3.14% · $4.68
  5. T+60 · 6mo ago −20.29%α −27.24% · $3.81
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Myriad Genetics filed an S-3 shelf registration to potentially raise up to $200 million through future offerings of common stock, preferred stock, depositary shares, debt securities, or warrants. This is a routine capital markets tool, not an immediate offering, and provides flexibility for opportunistic fundraising. The company recently secured a $125 million term loan, indicating it has near-term liquidity but may seek additional capital for strategic needs.

Key Financial Metrics

Offering Size
$200.0M

Key Facts

  • Myriad Genetics filed an S-3 shelf registration to register up to $200 million of securities.
  • The filing allows for future offerings of common stock, preferred stock, depositary shares, debt securities, or warrants, either individually or in units.
  • The shelf registration is a procedural step and does not mean an immediate offering is taking place.
  • The company recently entered into a $125 million secured term loan in July 2025, which was used to repay its previous credit facility.
  • The company reported a net loss of $358 million for the nine months ended September 30, 2025, and has a history of negative cash flow from operations.

Financial Impact

Up to $200 million in potential future dilution or debt issuance.

dilutiondebtcash

Risk Factors

  • Future equity offerings could dilute existing shareholders.
  • Future debt offerings could increase the company's leverage and interest expense.
  • The company's financial performance, including recent losses and impairment charges, may affect the terms and success of any future offering.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 9 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0000899923-26-000020
Exhibit: exfilingfees.htm0000899923-26-000020
Exhibit: ex231eyconsentfeb2026.htm0000899923-26-000020
Document: myriad-2026sx322026.htm0000899923-26-000020
Document: myriad-sx3x51opinionfebrua.htm0000899923-26-000020
Document: 0000899923-26-000020-index-headers.html0000899923-26-000020
Document: 0000899923-26-000020-index.html0000899923-26-000020
Document: 0000899923-26-000020.txt0000899923-26-000020
CONTEXT: 10-Q (2025-11-04)0000899923-25-000112

Track record

16 reports on MYGN

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.54% at T+5 after the Oct 20, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $5.57 Now $5.57 −0.00% settles Nov 18
  2. Nov 9, 20267d ago 8-K Neutral 2/10 Entry $5.67 to $5.72 Now $5.57 −1.76% ▲ +0.88% −0.44% vs SPY
  3. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $6.29 to $5.92 Now $5.57 −11.45% ▼ −5.88% −6.19% vs SPY
  4. Nov 4, 202612d ago 8-K Mixed 6/10 Entry $6.29 to $5.92 Now $5.57 −11.45% ▼ −5.88% −6.19% vs SPY
  5. Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $6.02 to $6.29 Now $5.57 −7.48% ▲ +4.49% +8.89% vs SPY
  6. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $6.63 to $6.67 Now $5.57 −15.99% ▲ +0.60% +0.99% vs SPY
  7. Oct 20, 202627d ago 8-K Bullish 7/10 Entry $5.54 to $5.57 Now $5.57 +0.54% ▲ +0.54% +0.02% vs SPY
  8. Oct 15, 20264w ago Press Release Neutral 1/10 Entry $3.98 Now $5.57 +39.95% No price data
  9. Oct 9, 20265w ago 8-K Neutral 3/10 Entry $4.20 to $4.08 Now $5.57 +32.62% ▼ −2.86% −2.85% vs SPY
  10. Sep 16, 20268w ago 8-K Neutral 3/10 Entry $3.86 to $4.14 Now $5.57 +44.30% ▲ +7.25% +6.12% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 8h 57m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 24, 2026